9th Annual Biomarkers Congress

Drug Design: Duke University

Total Score People Score Events Score
46 41 24
Date Event Presentation Speakers
July 11, 2010 Translational Cancer Medicine 2010 (USA) Utilization of genomic signatures to guide therapeutic decisions Joseph R. Nevins
May 4, 2010 Biomarker World Congress 2010 Evolutionary Genetics of Alzheimer’s Disease Allen D. Roses
January 22, 2010 2010 Gastrointestinal Cancers Symposium Differentiating the Management of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus Hope E. Uronis
Radiation Oncologist Brian G. Czito
September 24, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers Using Proteomics and Established Patient Cohorts to Address Relevant Clinical Biomarker Needs: The MURDOCK Study J. Will Thompson
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety KEYNOTE PANEL DISCUSSION Mitchell W. Krucoff
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Critical Path Meets Cardiac Safety: A Novel, Collaborative Paradigm for Cardiac Safety Evaluation Mitchell W. Krucoff
May 11, 2009 Patient Recruitment in Clinical Trials Current Challenges in Phase I Pediatric Research Barry Mangum
February 23, 2009 3rd Clinical Trial Billing & Research Compliance CASE PERSPECTIVE Lynda A Szczech, Jennifer Holcomb
January 5, 2009 High Content Analysis High-Content Fluorescent Microscopy Imaging Approaches to Measure Rescue of Neurodegenerative Primary Neurons in a Drug Discovery Platform Oscar Joseph Trask
September 29, 2008 Genomic Biomarkers Lost in Translation: Factors Affecting the Clinical Uptake of Molecular Diagnostics Judd Staples
Integration of Metabolic and Transcriptomic Profiling for Understanding of Diabetes and Obesity Mechanisms Christopher B. Newgard
September 29, 2008 Biomarker Data Analysis Integrating Omics and Clinical Data to Better Understand Disease Mechanism and Predict Treatment Outcome A. Jamie Cuticchia
September 29, 2008 Metabolic Biomarkers Integration of Metabolic and Transcriptomic Profiling for Understanding of Diabetes and Obesity Mechanisms Christopher B. Newgard
September 29, 2008 Biomarker Data Analysis Integration of Metabolic and Transcriptomic Profiling for Understanding of Diabetes and Obesity Mechanisms Christopher B. Newgard
September 16, 2008 Structural Biology and Activation Mechanisms of Membrane Receptors (S1) Structure, Function and Crosstalk of G-Protein-Coupled Receptors (GPCRs) Robert Lefkowitz
July 19, 2008 22nd Annual Symposium of The Protein Society Awards Reception & Banquet Jane Richardson
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty H Kim Lyerly, Neil Spector, Raj K. Puri
Introduction H Kim Lyerly
Panel Discussion: Obstacles to Development--Ten Barriers to Proving Agents are Effective and Safe Kim H Lyerly
Proof of Concept to the Clinical Investigator: What are Meaningful Endpoints in Early Stage Development Neil Spector
Panel Discussion Neil Spector
Cancer Vaccines and Immunotherapy H Kim Lyerly, Raj K. Puri
May 30, 2008 ASCO Annual'08 Meeting cancer prevention/epidemiology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
geriatric oncology-- Internal Medicine for the Oncologist Harvey Jay Cohen
health services research-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
tumor biology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
May 18, 2008 MAGI’s 2008 Clinical Trial Agreements, Budgets & Regulatory Conference – EAST Track B: Budgets NIH Grants & Proposals Rebbecca A. Moen
March 30, 2008 Nuclear Receptors: Steroid Sisters Steroid Receptor and Coregulator Structure and Function Donald P. McDonnell
Workshop 1 - Hot Topics: Cancer/Signaling Donald P. McDonnell
March 30, 2008 Nuclear Receptors: Orphan Brothers Steroid Receptor and Coregulator Structure and Function Donald P. McDonnell
Workshop 1 - Hot Topics: Cancer/Signaling Donald P. McDonnell
December 1, 2007 47TH American Socieity of Cell Biology Translocation of Mammalian Lipid Droplets into the Chlamydia trachomatis Parasitopherous Vacuole. Raphael H Valdivia
Neuronal Cell Biology Michael D Ehlers
Positioning Endocytic Zones and AMPA Receptor Cycling in Dendritic Spines. Michael D Ehlers, J Lu, T D Helton, T A. Blanpied, T M Newpher
Structural Integrity of the Mature Neuromuscular Junction Requires an Ankyrin-B-dependent Localization of β- G. Ayalon, V Bennett, J. Q. Davis
Chromatin Architecture and Remodeling Laura Rusche
Building Silent Chromatin: Dynamics of SIR Spreading in Yeast. Laura Rusche, P Lynch
The Role of Cell Traction Force in Fibronectin Fibrillogenesis. Harold P Erickson
Stem Cells, Small RNAs, and Self-Renewal. S Grivna
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Li Huang
Session 11: Small Molecules with Novel Mechanisms of Action and Potent Anti-HIV-1 Activity Against Multiple Genetic Subtypes of HIV-1 (10:40-11:00) Li Huang
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 4: New Trials and Genomic-based Design Stephen L GEORGE, Joseph R. Nevins
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) Julie M. Hall
NUCLEAR HORMONE RECEPTORS: Pro-Inflammatory Actions of Thiazolidinediones (TZDs) in Macrophages: Mechanism and Implications for Human Health (15:15-15:45) Julie M. Hall
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Eight Annual Metabolic Biomarkers: METABOLIC BIOMARKER DISCOVERY (08:30-11:00) Rima Kaddurah-Daouk Kaddurah-Daouk
Eight Annual Metabolic Biomarkers; METABOLIC BIOMARKER DISCOVERY: METABOLIC BIOMARKER DISCOVERY: Metabolomics for Mapping Disease Signatures and Drug Response Phenotypes (08:35-09:05) Rima Kaddurah-Daouk Kaddurah-Daouk
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.